The resilient attitude of Indian pharmaceutical companies coupled with quick innovative solutions has ensured consistency in supply chains amid unprecedented challenges
The Department has been working continuously to ensure a stable long-term policy environment and reduce the compliance burden on the Industry.
Call it one of the most striking turnarounds in the Indian pharma sector this fiscal year
The Union Budget makes a clear and timely choice by placing biopharma at the centre of India’s next manufacturing wave
Growth across inorganic & organic chemicals, fertilisers, pharmaceuticals, cosmetics, soaps and detergents
The development marks an important step in Sigachi's strategic focus on expanding its presence in complex, high-value specialty APIs, aligned with global demand for advanced therapies in rare and chronic disease segments
The company recorded revenue of Rs. 1,065 crore in the third quarter of FY26
The company’s consolidated revenue from operations rose to Rs. 361.13 crore in Q2 FY26 and Rs. 707.67 crore for the first half
The accelerated review covers WCK 5222 for multiple critical infections
For 2026 onwards, CPHI and PMEC India are evolving into two distinct, specialized shows
Subscribe To Our Newsletter & Stay Updated
